Assignee
TEXAS BIOTECHNOLOGY CORP
US·34 granted patents·1 pending application·1,447 citations·filing 1994–2002
Top patents by PatentIndex Score
35 records- 0197US6545014B2Method of treating glaucomaTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Apr 8, 2003·50 cites·3 claims
- 0297US5571821ASulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Nov 5, 1996·125 cites·91 claims
- 0395US5594021AThienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1995·Granted Jan 14, 1997·88 cites·174 claims
- 0492US5962490AThienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Oct 5, 1999·93 cites·97 claims
- 0592US5510332AProcess to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides thereforTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Apr 23, 1996·151 cites·15 claims
- 0689US5444050ABinding of E-selectin or P-selectin to sialyl Lewisx or sialyl-LewisaTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Aug 22, 1995·93 cites·19 claims
- 0788US6458805B2Formulation of sulfonamides for treatment of endothelin-mediated disordersTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Oct 1, 2002·30 cites·65 claims
- 0888US5977117ASubstituted phenyl compounds and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Nov 2, 1999·72 cites·73 claims
- 0988US5591761AThiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Jan 7, 1997·67 cites·93 claims
- 1085US6723711B2Propanoic acid derivatives that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Apr 20, 2004·35 cites·13 claims
- 1183US6013655AThieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1998·Granted Jan 11, 2000·22 cites·27 claims
- 1282US5783705AProcess of preparing alkali metal salys of hydrophobic sulfonamidesTEXAS BIOTECHNOLOGY CORP·Filed 1997·Granted Jul 21, 1998·48 cites·11 claims
- 1381US6248767B1Formulation of sulfonamides for treatment of endothelin-mediated disordersTEXAS BIOTECHNOLOGY CORP·Filed 1997·Granted Jun 19, 2001·46 cites·66 claims
- 1481US6194448B1N, N-disubstituted amides that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Feb 27, 2001·42 cites·17 claims
- 1578US6632829B2Sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Oct 14, 2003·9 cites·55 claims
- 1678US6420567B1N-heteroaryl aryl-substituted thienyl-furyl-and pyrrolyl-sulfonamides and derviatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1997·Granted Jul 16, 2002·32 cites·73 claims
- 1778US5919768ADi- and trivalent small molecule selectin inhibitorsTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jul 6, 1999·61 cites·9 claims
- 1877US6432994B1Sulfonamides for treatment of endothelin-mediated disordersTEXAS BIOTECHNOLOGY CORP·Filed 1998·Granted Aug 13, 2002·30 cites·18 claims
- 1977US6030991ABenzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Feb 29, 2000·47 cites·125 claims
- 2077US5622937ACompositions and methods of inhibiting the binding of E-selectin or P-selectin or sialyl-Lewisx or sialyl-LewisaTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Apr 22, 1997·56 cites·6 claims
- 2176US6265428B1Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 24, 2001·34 cites·14 claims
- 2275US6331637B1N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Dec 18, 2001·26 cites·60 claims
- 2375US6087330AProcess to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides thereforTEXAS BIOTECHNOLOGY CORP·Filed 1998·Granted Jul 11, 2000·33 cites·17 claims
- 2473US6342610B2N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jan 29, 2002·18 cites·52 claims
- 2567US5804585AThieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Sep 8, 1998·22 cites·28 claims
- 2666US6262084B1Compounds that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 17, 2001·18 cites·10 claims
- 2763US5736509ACyclic peptide surface feature mimics of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1994·Granted Apr 7, 1998·19 cites·41 claims
- 2860US6376523B1Benzenesulfonamides and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Apr 23, 2002·19 cites·97 claims
- 2958US5776907AMitomycin oligonucleotide conjugatesTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jul 7, 1998·21 cites·16 claims
- 3055US5958905APhosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Sep 28, 1999·10 cites·92 claims
- 3154US5712387AHigh yield stereospecific mannosylationTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Jan 27, 1998·8 cites·4 claims
- 3252US6329387B2Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Dec 11, 2001·10 cites·5 claims
- 3349US6713604B1Process to inhibit binding of the integrin α4β1 , to VCAM-1 fibronectin and cyclic peptides thereofTEXAS BIOTECHNOLOGY CORP·Filed 1996·Granted Mar 30, 2004·7 cites·4 claims
- 3449US2003079238A1Polynucleotide encoding a human junctional adhesion protein (JAM-2)TEXAS BIOTECHNOLOGY CORP·Filed 2002·Application pending·0 cites
- 3546US6384261B1Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelinTEXAS BIOTECHNOLOGY CORP·Filed 1998·Granted May 7, 2002·5 cites·17 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →